Evt-401 and Impurities
EVT-401
EVT-401 (P2X7 receptor antagonist-1), a purinergic P2X7 receptor antagonist, demonstrates efficacy in combating neuroinflammation [1].
Formula:
C22H20F4N2O3
Color and Shape:
Liquid
Molecular weight:
436.4
Ref: TM-T74409
5mg | To inquire | ||
50mg | To inquire |
Estimated delivery in United States, on Thursday 5 Dec 2024
Ref: 4Z-E-203006
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Wednesday 11 Dec 2024
Ref: 4Z-E-203002
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Wednesday 11 Dec 2024
Ref: 4Z-E-203004
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Wednesday 11 Dec 2024
Ref: 4Z-E-203001
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Wednesday 11 Dec 2024
Ref: 4Z-E-203003
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Wednesday 11 Dec 2024
Ref: 4Z-E-203005
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Wednesday 11 Dec 2024